Dr. Jitendra Singh has said that the Cervical Cancer Vaccine developed by India is affordable and more effective.
While thanking Prime Minister Shri Narendra Modi for launching Mission "Suraksha" during the Covid pandemic and offering unflinching support to the government's Vaccine programme, the Minister hailed the Department of Biotechnology in the Ministry of Science & Technology for developing this Human Papilloma Virus (HPV) vaccine which is unique because of being quadrivalent and thus being highly effective HPV 6,11 and 16,18 which are closely associated with Cervical Cancer in women. He said,the same department had earlier earned worldwide laurels by coming out with first DNA Vaccine for Covid during the pandemic.
In an exclusive interview session at a Health Conclave organised by NDTV at Hotel Hyat here, Dr Jitendra Singh said, Quadrivalent HPV Vaccine is a boon for the Indian population where mortality among women due Cervical Cancer is reported to be around 1 lakh annually and over 90% of these women have a history of HPV infection.
Copyright © 2017 Indian Grapevine a unit of Integrated Media Enterprises
